IMP3 expression in human ovarian cancer is associated with improved survival.
Noske A, Faggad A, Wirtz R, Darb-Esfahani S, Sehouli J, Sinn B, Nielsen FC, Weichert W, Buckendahl AC, Röske A, Müller B, Dietel M, Denkert C.
Noske A, et al.
Int J Gynecol Pathol. 2009 May;28(3):203-10. doi: 10.1097/PGP.0b013e318189a724.
Int J Gynecol Pathol. 2009.
PMID: 19620937